The novel approach of the medication represents a major advance in the care of type 2 diabetes. Distinct from existing drugs, tirzepatide targets dual pathways – GLP-1 and glucose-dependent insulinotropic polypeptide https://tirzepatide-peptide367595.blogcudinti.com/42155428/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment